Germany’s Cannabis Act (Cannabisgesetz, CanG), which came into force on April 1, 2024, fundamentally changed the legal landscape for cannabis in one of Europe’s largest economies. Adults in Germany now have legal access to cannabis through multiple pathways—but the regulatory framework differs substantially from the retail dispensary model that many consumers associate with legal cannabis markets. Understanding which access channels exist, how they work, and what rules apply is essential for anyone looking to engage with Germany’s legal cannabis market.
Germany’s Legal Cannabis Framework: An Overview
Germany’s CanG operates on a two-pillar model. The first pillar, operative since April 2024, decriminalised cannabis possession and personal cultivation for adults aged 18 and over. The second pillar, rolling out progressively from mid-2024, established the framework for cannabis social clubs as a collective cultivation and distribution mechanism.
Importantly, Germany has not legalised commercial retail sale of cannabis for recreational use through shops or dispensaries. The CanG explicitly excludes a commercial retail model, at least in its current form. This distinguishes the German approach from the dispensary-based retail markets in the United States, Canada, or the Netherlands.
Personal Possession Limits
Under the CanG, adults aged 18 and over may legally possess up to 25 grams of cannabis in public and up to 50 grams at their primary residence. Adults may also cultivate up to three cannabis plants per person for personal use. Public consumption is permitted but prohibited within specific exclusion zones: schools, kindergartens, playgrounds, sports facilities, and pedestrian zones in city centres between 7:00 AM and 8:00 PM.
Pathway 1: Medical Cannabis Prescription
The most established and regulated pathway for accessing cannabis in Germany is through the medical system. Medical cannabis has been available through prescription in Germany since 2017, and the framework has matured significantly over subsequent years. German physicians can prescribe cannabis flowers, extracts, and other cannabis-based medicines for patients where they consider it clinically appropriate.
How to Get a Medical Cannabis Prescription
The process of obtaining a medical cannabis prescription in Germany involves a consultation with a licensed physician—either in person or increasingly through telemedicine platforms. The physician assesses the patient’s medical history, current condition, and whether cannabis is an appropriate treatment option. If the physician determines a prescription is warranted, they issue a standard medical prescription that can be filled at any licensed pharmacy that stocks cannabis products.
The medical cannabis prescription route requires a genuine clinical basis—patients cannot obtain prescriptions purely for recreational use through the medical system. However, the range of conditions for which physicians in Germany may consider cannabis includes chronic pain, multiple sclerosis, chemotherapy-related nausea, anxiety disorders, sleep disturbances, and other conditions where conventional treatments have been insufficient.
Online Medical Cannabis Consultations
Telemedicine has significantly streamlined access to medical cannabis consultations in Germany. Several licensed platforms now offer physician consultations via video call, removing the need for in-person clinic visits. Among these, Weed.de provides online physician consultations from €9.95, with prescriptions accessible through a network of over 300 partner pharmacies stocking more than 1,600 cannabis flower varieties and extract products from licensed producers. The platform’s 4.7/5 user rating reflects the combination of accessibility and product range it has developed within the German medical cannabis system.
Pathway 2: Cannabis Social Clubs (CSCs)
Cannabis social clubs became available to German residents from July 2024 under the CanG’s second pillar. A CSC is a registered non-profit association of adults who collectively cultivate cannabis for their members’ personal use.
How CSCs Work
Each cannabis social club is permitted a maximum of 500 members and may distribute up to 25 grams of cannabis per member per day and up to 50 grams per month. Members must be adults (18+) residing in Germany. CSCs may not sell cannabis commercially or distribute to non-members. The cannabis is cultivated collectively by the association and distributed at cost to cover operational expenses—not for profit.
Joining a CSC typically involves a formal membership application, compliance with the club’s internal rules, and adherence to the distribution limits set by the CanG. The quality assurance available through CSCs varies by club, as they are not subject to the pharmaceutical production standards that apply to licensed medical cannabis producers.
What You Cannot Do Under German Cannabis Law
The CanG imposes clear restrictions alongside the access it creates. Adults under 18 may not legally access cannabis under any pathway. Consumption in restricted public zones (school areas, playgrounds, etc.) during restricted hours is prohibited. Purchasing cannabis from unlicensed sources (outside CSCs or the medical system) remains illegal. Commercial retail sale of cannabis for non-medical purposes is not authorised under the current framework.
The Market Behind the Legal Access
Germany’s legal cannabis market—primarily the medical sector, which predates the CanG—had reached an estimated €2.04 billion in 2024 and is projected to grow to €9.66 billion by 2033. Germany is currently the world’s largest medical cannabis importer, with 134 tons imported annually, reflecting the scale of licensed patient demand and the breadth of products available through the medical prescription pathway.
Conclusion
Buying cannabis legally in Germany means engaging with one of two established pathways: the medical prescription system, which provides access to a wide range of quality-assured products through licensed pharmacies, or a cannabis social club, which provides member-based access to collectively cultivated cannabis. Commercial retail dispensaries for recreational cannabis do not yet exist in Germany under the current framework. For adults seeking the broadest product range with full quality documentation and medical guidance, the prescription pathway remains the most developed and transparent option in the German legal market.
